Donor antigen-independent effector mechanisms of graft rejection: a novel cell surface target of IL-2-activated natural killer cells

Transplant Proc. 1999 Feb-Mar;31(1-2):787-8. doi: 10.1016/s0041-1345(98)01768-0.
No abstract available

MeSH terms

  • Animals
  • Bronchoalveolar Lavage Fluid / cytology
  • Bronchoalveolar Lavage Fluid / immunology
  • Cyclosporine / therapeutic use
  • Cytotoxicity, Immunologic
  • Dogs
  • Graft Rejection / immunology*
  • Humans
  • Interleukin-2 / pharmacology
  • Interleukin-2 / physiology*
  • Killer Cells, Natural / immunology*
  • Lung Transplantation / immunology*
  • Lymphocyte Activation*
  • Recombinant Proteins / pharmacology
  • Transplantation, Homologous

Substances

  • Interleukin-2
  • Recombinant Proteins
  • Cyclosporine